Rocket Lab Loses Key Line: Here’s My Plan for the Stock (And One Other)

Readers will see below that $10,000 Portfolio member Rocket Lab (RKLB) has lost its 50-day simple moving average (SMA). This will likely force at least some professional managers to lighten up on their exposure this week. So, will we.

I will leave my now dreamy $185 price target where it is for now, but the plan is to get out of a few shares and add them back in as RKLB approaches the 200-day SMA down around $74.

Other Recent Portfolio News

Alto Ingredients

On Monday, analyst Eric Stine of Craig-Hallum reiterated a “buy” rating on Alto Ingredients (ALTO) as well as his $8 price target. Stine is rated at five stars out of five by TipRanks. Over the past two years, he has had a 50% success rate with an average return of 28.5%.

Amazon

On Tuesday morning, a JPMorgan research note reported that the firm’s analysis of Amazon Prime suggests potential value to U.S.-based members of more than 10-times the annual cost. Unbundling of Prime’s components, according to the report, indicates an estimated value of $1,440 per year, versus the $139 annual cost. Hence a price increase could be slated for 2027. Amazon (AMZN) remains a best idea at JPMorgan with an Overweight rating and $330 price target.

On Monday, analyst Brian White of Monness reiterated a “buy” rating on AMZN while increasing his price target from $244.39 to $315 (Don’t ask me about the pennies). White is rated at five stars out of five by TipRanks. Over the past two years, he has had a 67% success rate with an average return of 28.4%.

Ocular Therapeutix

On Monday, analyst Tazeen Ahmad of Bank of America reiterated a “buy” rating on Ocular Therapeutix (OCUL) as well as her $27 price target. Ahmad is rated at four stars out of five by TipRanks. Over the past two years, she has had a 58% success rate with an average return of 9.9%.

On Monday, analyst Yi Chen of HC Wainwright reiterated a “buy” rating on OCUL while increasing his price target from $21 to $25. Chen is rated at one star out of five by TipRanks. Over the past two years, he has had a 37% success rate with an average return of 0.1%.

Ondas

On Monday, Ondas (ONDS) announced that it has secured more than $40 million in aggregate new orders during June for autonomous defense systems. This includes Counter-UAS solutions, Loitering Munition Systems, ground systems and related defense services from governmental and defense-focused clientele across multiple global markets. These new orders bring Ondas’ second-quarter-to-date order activity to more than $150 million.

Palantir Technologies

On Tuesday morning, Zeta Global (ZETA) and Palantir (PLTR) announced a strategic partnership to build an enterprise AI infrastructure layer that will connect operational intelligence, customer intelligence, and marketing execution. This is intended to combine AI infrastructure with Zeta’s intelligent decisioning and trusted data to bring a new standard of data-driven, agentic marketing to the enterprise.

SoFi Technologies

On Tuesday morning, SoFi Technologies (SOFI) announced the launch of Composer, an AI-powered investing platform that helps investors move from investing ideas to automated execution within minutes. In a statement, the firm stated, “The platform offers three ways to get started. Members can: Design a custom strategy: An investor who believes technology stocks outperform in strong markets but wants to move into ETFs during periods of weakness can describe that idea in plain English, and Composer will help the investor build, test, and automate a rules-based strategy reflecting those inputs.”

Monday’s Intentions vs. Monday’s Actual Trades

I have some explaining to do. By the time my piece was published on Monday, these limits were not realistic. I normally do not violate limits expressed here in this column in implementing the corresponding trades in the actual portfolio. However, having to wait until our readers can act before we do, not only creates price discovery mismatches at times, but can create opportunity for human error.

On Monday, despite putting a $126 limit on the PLTR sell order, I, in error, sold 4 shares of PLTR at the market. The execution was not necessarily a good one, but given that I did not mind raising some cash, I did not cover the error and let it stand.

– Sell 4 shares of PLTR at $126 or better.
– Sold 4 shares of PLTR (in error) at $119.425.

– Buy 5 shares of PL at $28 or better.
– Nothing Done

Tuesday’s Intentions

– Sell 3 shares of RKLB at or close to the last sale of $95.25.

– Buy 5 shares of PL at $27.50 or better.

Current $10K Portfolio Positions

Long 125 shares of ALTO at $5.635. Target Price: $9. Last sale: $5.15.

Long 3 shares of AMZN at $258.0567. Target Price: $324. Last sale: $231.00.

Long 60 shares of EVLV at $5.9895. Target Price: $8.50. Last sale: $5.45.

Long 200 shares of OCUL at $8.271. Target Price: $11. Last sale: $9.77.

Short one OCUL $11 Sep 18th call at $1.65, Last sale: $1.85.

Short one OCUL $9 July 17th call at $0.90. Last sale: $1.50.

Long 150 shares of ONDS at $9.7624. Target Price: $14. Last sale: $8.56.

Long 20 shares of PL at $32.865. Target Price $55. Last sale: $27.30.

Long 6 shares of PLTR at $131.8533. Target Price: $194. Last sale: $119.92.

Long 8 shares of RKLB at $77.9288. Target Price: $185. Last sale: $95.25.

Long 35 shares of RXT at $6.4529. Target Price: $9. Last sale: $6.40.

Long 150 shares of SIDU at $3.0909. Target Price: $6. Last sale: $2.94.

Long 135 shares of SOFI at $15.8617. Target Price: $24. Last sale: $16.65.

Short one SOFI August 21st $20 call at $1.02. Last sale: $0.86.

Long 20 shares of SWBI at $16.125. Target Price: $19. Last sale: $16.18.

Long 35 shares of VELO at $12.3231. Target Price: $36. Last sale: $22.66.

Cash: $554.81.

Portfolio Value: $11,100.31, +11.0% from inception on March 24th.

At the time of publication, Guilfoyle had positions in ALTO, AMZN, EVLV, OCUL, ONDS, PL, PLTR, RKLB, RXT, SIDU, SOFI and VELO.